Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
Effect of inhibitors (PP242), PKI402 and (MTOR) in their combination with MEK cytometry on cancer cell cells
تأثير مثبطات (PP242) و (PKI402) و (MTOR) في اتحادها مع مثبط (MEK) سليومتنب على خلايا النخاع السرطانية
Subject
:
Faculty of Applied Medical Sciences
Document Language
:
Arabic
Abstract
:
Acute myeloid leukaemia (AML) is a type cancer in which myeloid cells proliferate unstoppably and lose the ability to differentiate into functional cells. AML patients generally have a poor outcome with standard chemotherapy and are associated with high relapse rates. Therefore, new therapies with lower toxicities and higher cure rates, such as targeted therapy must be tested. Cellular signaling pathways such as the mammalian target of rapamycin (mTOR) pathway and the MAPK/ERK pathway are often hyper-activated or deregulated due to genetic abnormalities in AML. Inhibitors of mTOR and MAPK/ERK pathways show promising results in different types of malignancies. In the current study we aimed to combine PI3K/mTOR inhibitors (PKI-402 and PP242) with a MAPK/ERK pathway inhibitor (Selumetinib; SEL) on AML cell lines and patient samples. Cell proliferation assays were performed to assess the effect of the drug. The Chou-Talalay multi-drug combination method, was used to determine the combination index (CI) values which measure the interaction between two drug combinations. Drug treated cells were analyzed by flow cytometry to assay apoptosis and cell cycle proliferation. In our cell proliferation experiments PKI-402 and PP242 demonstrated synergistic effects when combined with SEL in HL60 and NB4. Increased apoptosis was observed when we combined PP242 or PKI-402 with SEL. The mTOR inhibitor alone did not induce apoptosis in primary cells. Primary patient samples showed varying results with the mTOR- MAPK/ERK inhibitor combinations. In conclusion, the combination of mTOR and MAPK/ERK inhibitors represents a potentially promising approach in the treatment of AML. A larger number of primary AML patient samples is needed to evaluate the effect of the combination. The mechanism under which these two pathways interact needs to be demonstrated. An extension of this study in preclinical animal models will be of great value.
Supervisor
:
Dr. Adel Mohammed Abunada
Thesis Type
:
Master Thesis
Publishing Year
:
1438 AH
2017 AD
Co-Supervisor
:
Dr. Farid Ahmed Yassin
Added Date
:
Sunday, April 16, 2017
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
منال عبد الغفور أسرار
Asrar, Manal Abdul Ghafoor
Researcher
Master
Files
File Name
Type
Description
39682.pdf
pdf
Back To Researches Page